Draft Genome Sequences of Bacillus cereus E41 and Bacillus anthracis F34 Isolated from Algerian Salt Lakes

Genome Announcements
Mohamed Seghir DaasRebecca J Case

Abstract

Two strains of Bacillus, B. cereus E41 and B. anthracis F34, were isolated from a salt lake in Aïn M'lila-Oum El Bouaghi, eastern Algeria, and Ain Baida-Ouargla, southern Algeria, respectively. Their genomes display genes for the production of several bioactive secondary metabolites, including polyhydroxyalkanoate, iron siderophores, lipopeptides, and bacteriocins.

References

Feb 12, 2008·BMC Genomics·Ramy K AzizOlga Zagnitko
Oct 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Michael Richter, Ramon Rosselló-Móra
May 15, 2010·Microbiology·Kinya HottaAndrew T Koppisch
May 8, 2015·Nucleic Acids Research·Tilmann WeberMarnix H Medema

❮ Previous
Next ❯

Citations

May 16, 2019·Environmental Microbiology·Ana-Belen Martin-CuadradoVíctor Parro
Mar 31, 2018·Genome Announcements·Mohamed Seghir DaasJohn C Vederas

❮ Previous
Next ❯

Software Mentioned

JSpecies
antiSMASH
RAST

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.